2 Results for "

aggregation kinetics

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "aggregation kinetics" in MCE Product Catalog:

1
1 Cited Publications
Referencia número: HY-137441
No. CAS: 1000999-96-1
Pureza:  99.52%
Synonyms: PU-HZ151
Target:  

HSP

Áreas de investigación:  

Neurological Disease Cancer

Icapamespib (PU-HZ151; PU-AD) is a selective, orally active inhibitor of Epichaperomes assembled by HSP90 with slow dissociation kinetics. Icapamespib can cross the blood-brain barrier (BBB) ??and induce epichaperome disassembly by non-covalently binding to HSP90, restoring the normal protein-protein interaction network. Icapamespib can specifically disrupt disease-related abnormal protein interaction networks, reduce neurotoxic protein aggregation and tumor cell survival signals. Icapamespib can be used in the research of neurodegenerative diseases such as Alzheimer's disease, as well as cancers such as glioblastoma and metastatic breast cancer .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-137441A
No. CAS: 2267287-26-1
Pureza:  98.67%
Synonyms: PU-HZ151 hydrochloride
Target:  

HSP

Áreas de investigación:  

Neurological Disease Cancer

Icapamespib (PU-HZ151; PU-AD) hydrochloride is a selective, orally active inhibitor of Epichaperomes assembled by HSP90 with slow dissociation kinetics. Icapamespib hydrochloride can cross the blood-brain barrier (BBB) ??and induce epichaperome disassembly by non-covalently binding to HSP90, restoring the normal protein-protein interaction network. Icapamespib hydrochloride can specifically disrupt disease-related abnormal protein interaction networks, reduce neurotoxic protein aggregation and tumor cell survival signals. Icapamespib hydrochloride can be used in the research of neurodegenerative diseases such as Alzheimer's disease, as well as cancers such as glioblastoma and metastatic breast cancer .
loading...
    loading...